August 15, 2025

Approved: HPV-Targeted Immunotherapy for Recurrent Respiratory Papillomatosis

Standard management has relied on repeated surgical debulking, which does not eradicate underlying HPV infection.

Conexiant

August 14, 2025

Who Benefits From Vaccine Misinformation?

US vaccination rates have declined in recent years, coinciding with increased public debate over vaccine safety and policy.

KFF Health News

August 14, 2025

Are Immigration Raids Sending Patients Online?

Clinics and health plans are expanding telehealth services as increased immigration enforcement has coincided with some patients, including immigrant families, delaying or avoiding in-person medical visits.

KFF Health News

August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant

August 07, 2025

Flu Treatment Linked to Lower Neuropsychiatric Risk in Pediatric and Adolescent Patients

Subgroup analyses demonstrated a greater reduction in neurologic events than psychiatric events, though the reduction in psychiatric events was not statistically significant.

Conexiant

August 06, 2025

Bimekizumab Sustains Psoriasis Response for 3 Years

A 3-year analysis of a phase IIIb trial found that bimekizumab, a dual interleukin-17A and interleukin-17F inhibitor, maintained high rates of skin clearance and demonstrated a consistent safety profile in patients with moderate-to-severe plaque psoriasis, including those who switched from secukinumab, an interleukin-17A inhibitor.

Conexiant

August 01, 2025

UTI Linked to Short-Term Spike in MI, Storke

Analysis of microbiologically confirmed UTIs reveals a transient increase in cardiovascular event rates, especially within 7 days of infection onset.

Conexiant

July 31, 2025

AAP Releases 2025-2026 Flu Guidance

Experts encourage early influenza vaccination in children to reduce severe illness and hospitalization, especially among medically vulnerable and underserved populations.

Conexiant

July 30, 2025

Ondansetron Cuts 7-Day Gastroenteritis Severity in Children, Study Finds

Home use of ondansetron following emergency care for pediatric gastroenteritis lowers the risk of moderate-to-severe illness within 7 days, without increasing serious adverse events.

Conexiant